Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice

被引:47
作者
Fukushima, A
Yamaguchi, T
Ishida, W
Fukata, K
Mittler, RS
Yagita, H
Ueno, H
机构
[1] Kochi Med Sch, Dept Ophthalmol, Nankoku, Kochi 7838505, Japan
[2] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30329 USA
[3] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30329 USA
[4] Juntendo Univ, Sch Med, Dept Immunol, Tokyo 113, Japan
关键词
D O I
10.4049/jimmunol.175.8.4897
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The 4-1BB receptor acts as a costimulator in CD8(+) T cell activation. Agonistic stimulation through this molecule by treatment with anti-4-1BB Abs has been demonstrated to inhibit various experimentally induced diseases in animals. However, the effect of anti-4-1BB Abs on experimental allergic diseases has not been reported. We investigated the effect of anti-4-1BB Abs on the development and progression of experimental allergic conjunctivitis in mice. To examine the effects of Abs during the induction or effector phase, actively immunized mice or passively immunized mice by splenocyte transfer were treated with agonistic anti-4-1BB Abs, blocking anti-4-1BB ligand Abs, or normal rat IgG. Eosinophil infiltration into the conjunctiva was significantly reduced in wild-type mice by the anti-4-1BB Ab treatment during either induction or effector phase. Th2 cytokine production by splenocytes and total serum IgE were significantly reduced by the anti-4-1BB All treatment, while IFN-gamma production was increased. The anti-4-IBB Ab treatment induced a relative increase of CD8-positive cell numbers in the spleens. Moreover, inhibition of eosinophil infiltration by the treatment with anti-4-1BB Abs was also noted in actively immunized IFN-gamma knockout mice. Taken altogether, in vivo treatment with agonistic anti-4-1BB Abs in either induction or effector phase inhibits the development of experimental allergic conjunctivitis, and this inhibition is likely to be mediated by suppression of Th2 immune responses rather than up-regulation of IFN-gamma.
引用
收藏
页码:4897 / 4903
页数:7
相关论文
共 37 条
[1]   Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions [J].
Blazar, BR ;
Lees, CJ ;
Martin, PJ ;
Noelle, RJ ;
Kwon, B ;
Murphy, W ;
Taylor, PA .
JOURNAL OF IMMUNOLOGY, 2000, 165 (09) :4901-4909
[2]   CD137 costimulatory T cell receptor engagement reverses acute disease in lupus-prone NZB x NZW F1 mice [J].
Foell, J ;
Strahotin, S ;
O'Neil, SP ;
McCausland, MM ;
Suwyn, C ;
Haber, M ;
Chander, PN ;
Bapat, AS ;
Yang, XJ ;
Chiorazzi, N ;
Hoffmann, MK ;
Mittler, RS .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1505-1518
[3]   Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance [J].
Foell, JL ;
Diez-Mendiondo, BI ;
Diez, OH ;
Holzer, U ;
Ruck, P ;
Bapat, AS ;
Hoffmann, MK ;
Mittler, RS ;
Dannecker, GE .
IMMUNOLOGY, 2004, 113 (01) :89-98
[4]  
FUJISHIMA H, 1995, CLIN EXP IMMUNOL, V102, P395
[5]   Presence of eotaxin in tears of patients with atopic keratoconjunctivitis with severe corneal damage [J].
Fukagawa, K ;
Nakajima, T ;
Tsubota, K ;
Shimmura, S ;
Saito, H ;
Hirai, K .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1999, 103 (06) :1220-1221
[6]   Exertion of the suppressive effects of IFN-γ on experimental immune mediated blepharoconjunctivitis in Brown Norway rats during the induction phase but not the effector phase [J].
Fukushima, A ;
Fukata, K ;
Ozaki, A ;
Takata, M ;
Kuroda, N ;
Enzan, H ;
Ueno, H .
BRITISH JOURNAL OF OPHTHALMOLOGY, 2002, 86 (10) :1166-1171
[7]   Dissection of antigen-specific humoral and cellular immune responses for the development of experimental immune-mediated blepharoconjunctivitis in C57BL/6 mice [J].
Fukushima, A ;
Ozaki, A ;
Jian, Z ;
Ishida, W ;
Fukata, K ;
Ueno, H ;
Liu, FT .
CURRENT EYE RESEARCH, 2005, 30 (04) :241-248
[8]   Ag-specific recognitiong activationg and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis [J].
Fukushima, A ;
Ozaki, A ;
Fukata, K ;
Ishida, W ;
Ueno, H .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (10) :4366-4374
[9]  
FUKUSHIMA A, IN PRESS EXP EYE RES
[10]  
FUKUSHIMA A, IN PRESS GRAEFES ARC